Images

Filter by

Table 1 Special Considerations in the Initiation of Quadruple Medical Therapy
Table 1: Special Considerations in the Initiation of Quadruple Medical Therapy
Figure 2 General Framework for Oral Pharmacological Therapy for Worsening Heart Failure With Reduced Ejection Fraction Ejection Fraction ≤40
Figure 2: General Framework for Oral Pharmacological Therapy for Worsening Heart Failure With Reduced Ejection Fraction (Ejection Fraction ≤40%)
Figure 1 Proposed Pathway for Decongestion Therapy in Worsening Heart Failure
Figure 1: Proposed Pathway for Decongestion Therapy in Worsening Heart Failure
Figure 5 Progression from Current Ischaemia with No Obstructive Coronary Artery Disease Treatment Guidelines
Figure 5: Progression from Current Ischaemia with No Obstructive Coronary Artery Disease Treatment Guidelines
Figure 4 The Diagnostic Process for Suspected Ischaemia with No Obstructive Coronary Artery Disease
Figure 4: The Diagnostic Process for Suspected Ischaemia with No Obstructive Coronary Artery Disease
Figure 3 Myocardial and Vascular Abnormalities
Figure 3: Myocardial and Vascular Abnormalities
Figure 2 Molecular Mechanisms of Vascular Dysfunction Including Oxidative Stress Cytokine Activation and Their Effects on Vasodilation Vasoconstriction and Vascular Remodelling
Figure 2: Molecular Mechanisms of Vascular Dysfunction, Including Oxidative Stress, Cytokine Activation, and Their Effects on Vasodilation, Vasoconstriction and Vascular Remodelling